RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Polyneuropathy
Interventions
DRUG

Rituximab

Rituximab

Trial Locations (1)

75015

Groupe Hospitalier Pitié-Salpétrière, Consultation de Pathologie Neuromusculaire, Bâtiment Babinski, Paris

All Listed Sponsors
collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

collaborator

University Hospital, Bordeaux

OTHER

collaborator

University Hospital, Limoges

OTHER

collaborator

Henri Mondor University Hospital

OTHER

collaborator

University Hospital, Marseille

OTHER

collaborator

Hospices Civils de Lyon

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00259974 - RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy | Biotech Hunter | Biotech Hunter